Loading company…
Progenity is a San Diego biotechnology company that develops and sells molecular and genetic testing products.
Based in California, US, and founded in 2010, Progenity, Inc. develops and commercializes molecular testing products, including genetic tests for prenatal and hereditary conditions. Harry Stylli is CEO. The company went public in 2020, selling 6.7 million shares at USD 15 each on the NASDAQ for USD 100.5 million, and in February 2021 it raised USD 25 million in PIPE funding from unspecified investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in